Letters
Managing osteoarthritis of the knee
BMJ 2005; 330 doi: https://doi.org/10.1136/bmj.330.7492.672-b (Published 17 March 2005) Cite this as: BMJ 2005;330:672
Conclusions about use of NSAIDs are misleading
- Florence Tubach, assistant professor of epidemiology (florence.tubach@bch.ap-hop-paris.fr),
- P Ravaud, professor of epidemiology,
- B Giraudeau, ssistant professor of biostatistics
- INSERM U738; Groupe Hospitalier Bichat-Claude Bernard (Assistance Publique—Hôpitaux de Paris); Faculté Xavier Bichat (Université Paris 7), 46 rue Henri Huchard, 75018 Paris, France
- INSERM U738; Groupe Hospitalier Bichat-Claude Bernard (Assistance Publique—Hôpitaux de Paris); Faculté Xavier Bichat (Université Paris 7), 46 rue Henri Huchard, 75018 Paris, France
- INSERM CIC 202, Faculté de Médecine, 2 bis Bd Tonnellé, 37032 Tours, France
EDITOR—The meta-analysis by Bjordal et al of randomised controlled trials assessing the efficacy of non-steroidal anti-inflammatory drugs (NSAIDs) in osteoarthritic knee pain is technically well done, but the authors' conclusions are misleading.1 They assert that the mean change in pain, as measured on a visual analogue scale, over placebo was 10.1 mm (95% confidence interval 7.4 to 12.8) and claim …
Log in
Log in using your username and password
Log in through your institution
Subscribe from £173 *
Subscribe and get access to all BMJ articles, and much more.
* For online subscription
Access this article for 1 day for:
£38 / $45 / €42 (excludes VAT)
You can download a PDF version for your personal record.